alpha-Adrenergic blockade in children with neuropathic and nonneuropathic voiding dysfunction

Area of Science:

• Pediatric Urology
• Pharmacology
• Urodynamics

Background:

• Inadequate bladder emptying is a prevalent urinary dysfunction in children.
• The use of alpha-blockers for pediatric bladder outlet obstruction is not well-established.
• Alpha-blocker therapy has demonstrated efficacy in adult men with similar conditions.

Purpose of the Study:

• To investigate the efficacy and safety of alpha-blocker therapy for treating inadequate bladder emptying in children.
• To explore the potential of alpha-1 adrenergic receptor antagonists in pediatric urinary dysfunction.

Main Methods:

• Seventeen children (ages 3-15) with poor bladder emptying due to various etiologies received doxazosin.
• Dosing was adjusted based on patient response and tolerance, with regular monitoring of symptoms and urodynamic parameters.
• Specialized assessments like cystometrography were used for patients with neurogenic bladder.

Main Results:

• Significant improvement in bladder emptying and/or symptomatology was observed in 82% of patients.
• Reduced post-void residual urine volume and increased maximum flow rates were noted in several patients.
• Positive outcomes included decreased leak point pressure in neuropathic bladders and resolution of hydronephrosis in posterior urethral valve cases.

Conclusions:

• Selective alpha-blocker therapy appears well-tolerated and effective for improving bladder emptying in diverse pediatric voiding disorders.
• Short-term follow-up suggests a potential role for alpha-blockers in managing pediatric urinary dysfunction.
• Further long-term studies are necessary to fully validate these findings.